A Multi-Scale AI Trial Simulation Platform for Precision Clinical Development
TrialSim.Tech™ is an advanced AI-powered platform built to model the biological and clinical complexity of oncology drug development through mechanistically grounded trial simulation. By integrating multimodal biomedical data including scientific literature, clinical trial data, molecular datasets, and longitudinal EHR records, TrialSim.Tech™ generates biologically informed virtual patient cohorts and indication-specific simulation models for predictive clinical decision support. TrialSim.Tech™ helps oncology teams optimize trial design, improve stratification, reduce risk, and accelerate development through mechanistic simulation.
Reducing Clinical Uncertainty with Mechanistic Trial Intelligence
TrialSim.Tech™ helps pharmaceutical and biotech teams reduce clinical trial risk by predicting efficacy, safety, and trial success probability before patient enrollment, enabling more reliable and cost-efficient study design. It accelerates development timelines through early mechanistic insights and improves patient stratification by identifying likely responders and non-responders using biologically grounded digital twin simulations. Unlike traditional PK/PD and statistical models, TrialSim.Tech™ integrates fragmented clinical and molecular data into a unified simulation framework to better capture real-world biological complexity. This enables more accurate, explainable predictions of trial outcomes, supporting stronger go/no-go decisions across both early- and late-stage development.
Key Features & Capabilities
Indication-Specific Multi-Scale Modeling
Curates and integrates biomedical, clinical trial, and EHR data to build enriched knowledge models grounded in molecular, cellular, tissue, and patient-level biology.
Virtual Patient Digital Twins
Generates diverse, biologically grounded virtual patient populations reflecting disease state, molecular subtype, prior treatment history, and clinical context.
In Silico Trial Simulation
Simulates trial scenarios across realistic virtual populations to compare eligibility criteria, patient stratification, dose and schedule selection, endpoints, and likely outcomes. Ability to perturb various features of patient digital twins to simulate the impact on trial.
Trial Outcome Analytics Engine
Quantifies key clinical endpoints including Kaplan–Meier median PFS, hazard ratios (drug vs control), objective response rate, and ranked adverse event risk profiles for decision support.
Contact Us
Would you like us to get in touch with you? Fill up the form & we will reach out to you
